姓名：趙賦  性別：男  職稱：副教授

招生類型：科學(xué)學(xué)位(碩)

招生專業(yè)：外科學(xué)（神外）(碩)

研究方向：腦腫瘤綜合治療的基礎(chǔ)與臨床轉(zhuǎn)化研究

電子信箱：zhaofu1024@126.com

社會任職

1. 中國抗癌協(xié)會神經(jīng)腫瘤專業(yè)委員會青年委員

2. 北京抗癌協(xié)會神經(jīng)腫瘤專業(yè)委員會青年委員

個人簡歷

1. 202201-      :首都醫(yī)科大學(xué) 副教授

2. 201812-      :北京市神經(jīng)外科研究所 副研究員

3. 201507-201906:北京大學(xué) 學(xué)習(xí)

4. 201301-201811:北京市神經(jīng)外科研究所 助理研究員，醫(yī)師

5. 200908-201212:北京市神經(jīng)外科研究所 實習(xí)研究員，醫(yī)師

6. 200208-200907:首都醫(yī)科大學(xué) 臨床醫(yī)學(xué)7年制

重要學(xué)術(shù)論文

1. Fu Zhao, Shi-wei Li #, Shun Zhang, Peng Li, Chi Zhao., Xiao-bin Zhao, Chun-Hong Wang, Jing Zhang, Bo Wang, Pi-nan Liu*.Phase II trial of icotinib in adult patients with neurofibromatosis type 2 and progressive vestibular schwannoma.Journal of Neurosurgery.2022.10.1-8.SCI

2. 5. Zhi-ming Liu, Zhe Han, Jun-mei Wang, Tao Sun, Wei Liu, Bo Li, Jian Gong, Chun-de Li*, Fu Zhao*, Yong-ji Tian*.Treatment and outcome of pediatric intracranial ependymoma after first relapse.Journal Neuro-Oncology.2022.157(3).385-396.SCI

3. Fu Zhao *, Yang Chen, Shi-Wei Li, Jing Zhang, Shun Zhang, Xiao-Bin Zhao, Zhi-Jun Yang, Bo Wang, Qi-Yang He, Lei-Ming Wang, Lei Xu, and Pi-Nan Liu *.Novel Patient-Derived Xenograft and Cell Line models for Therapeutic Screening in NF2-associated Schwannoma.Journal of Pathology.2022.257(5).620-634.SCI

4. Jie Lin #, Shi-wei Li #, Jing Zhang, Fu-hao Chu, Cheng-ze Li, Zhi-xu Bie, Han-lu Tang, Shan Gao, Ping Li, Meng-ting Liao, Tian-xi Xin, Fu Zhao *, Pi-nan Liu * and Xia Ding *.Qu-Du-San-Jie Decoction Induces Growth Inhibition and Vascular Normalization in NF2-Associated Vestibular Schwannoma.Frontiers in Pharmacology.2022.13.941854.SCI

5. 2Zhi-Wei Zhang #, Xufei Teng #, Fu Zhao #, Chunhui Ma #, Jing Zhang, Mengqi Chang, Yongji Tian, Chunde Li, Zhang Zhang, Shuhui Song *, Yamei Niu *, Pinan Liu *, Wei-Min Tong *.METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma.Cell Reports.2022.41(4).111530.SCI

6. Fu Zhao#, Zhi-Wei Zhang#, Jing Zhang , Shun Zhang, Heng Zhang , Chi Zhao, Yang Chen , Lin Luo , Wei-Min Tong, Chunde Li , Yamei Niu* and Pinan Liu*. Loss of 5-hydroxymethylcytosine as an epigenetic signature that correlates with poor outcomes in patients with medulloblastoma. Frontier in Oncology.2021.11.603686.SCI

7. Shi-wei Li, Jing Zhang, Han-lu Tang, Peng Li, Bo Wang, Fu Zhao*, Pinan Liu*.Establishment of nomograms for the prediction of useful hearing loss in patients with neurofibromatosis type 2.Journal of Neuro-Oncology.2021.155(3).373–381.SCI

8. 趙賦，王博，李仕維，王興朝，張晶，王振民，李朋，楊智君，劉丕楠*.應(yīng)用國產(chǎn)化多通道聽覺腦干植入設(shè)備重建2型神經(jīng)纖維瘤病患者聽覺功能的臨床試驗研究.中華神經(jīng)外科雜志.2021.37(4).369-374.核心期刊

9. Fu Zhao#, Tao Wu#, Lei-ming Wang, Jing Zhang, Heng Zhang, Shi-wei Li, Shun Zhang, Peng Li, Bo Wang, Lin Luo, and Pi-nan Liu*.Survival and prognostic factors of adult intracranial ependymoma: A single-institutional analysis of 236 patients.American Journal of Surgical Pathology.2021.45(7). 979-987.SCI

10. Tao Wu, Zhi-Wei Zhang, Shiwei Li, Bo Wang, Zhijun Yang, Peng Li, Jing Zhang, Wei-Min Tong, Chunde Li, Fu Zhao, Yamei Niu*, Pinan Liu*. Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma.Clin Epigenetics.2020.12(1).19.SCI

11. 7. Tao Wu, Pei-ran Qu, Shun Zhang, Shi-wei Li, Jing Zhang, Bo Wang, Pinan Liu, Chun-de Li, Fu Zhao*.The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases.Scientific Reports.2020.10.9769.SCI

12. 張晶，楊智君，張順，陳震，趙赤，吳濤，王博，劉丕楠，趙賦*.小腦腦橋角區(qū)惡性周圍神經(jīng)鞘瘤的臨床和病理學(xué)特征分析.中華神經(jīng)外科雜志.2019.35 (5).448-453.核心期刊

13. 吳濤，劉丕楠，趙賦*.室管膜瘤分子生物學(xué)的研究進展.中華神經(jīng)外科雜志.2019.35 (2).207-209.核心期刊

14. Fu Zhao, Shun Zhang, Jiang Du, Yang Chen, Bo Wang, Jing Zhang, Qiyang He, Luo Lin, Li Zhang, Yanbing Yu, Pinan Liu*.Comparison of Clinical, Histopathological, and Genomic Features Between Malignant Peripheral Nerve Sheath Tumors and Cellular Schwannomas of the Eighth Cranial Nerve: A Case Series.World Neurosurgery.2019.122.e487-e497.SCI

15. Fu Zhao*, Bo Wang, Zhijun Yang, Qiangyi Zhou, Peng Li, Xingchao Wang, Jing Zhang, Junting Zhang, Pinan Liu*.Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.Journal of Neuro-Oncology.2018.139(2).333–340.SCI

16. 趙賦，張晶，李春德*.髓母細胞瘤的分子生物學(xué)研究進展.中華神經(jīng)外科雜志.2018.34 (12).1287-1290.核心期刊

17. Fu Zhao*, Bo Wang, Zhijun Yang, Qiangyi Zhou, Peng Li, Xingchao Wang, Jing Zhang, Junting Zhang, Pinan Liu*.Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation..Journal of Neuro-Oncology.2018.138 (2).417–424.SCI

18. 13. Qiangyi Zhou (#), Zhijun Yang, Zhenmin Wang, Bo Wang, Xingchao Wang, Chi Zhao, Shun Zhang, Tao Wu, Peng Li, Shiwei Li, Fu Zhao*, Pinan Liu*.Awake craniotomy for assisting placement of auditory brainstem implant in NF2 patients.ACTA OTO-LARYNGOLOGICA.2018.138(6).548–553.SCI

19. 張順，劉丕楠，趙賦*.神經(jīng)鞘瘤的分子遺傳學(xué)研究進展.中華神經(jīng)外科雜志.2017.33(9).966-969.核心期刊

20. 趙赤，劉丕楠，趙賦*.腦膜瘤的分子生物學(xué)研究進展.中華神經(jīng)外科雜志.2017.33(2).202-205.核心期刊

21. Li P, Yang Z, Wang Z, Zhou Q, Li S, Wang X, Wang B, Zhao F, Liu P.Clinical features of clear cell meningioma: a retrospective study of 36 cases among 10,529 patients in a single institution.Acta Neurochir (Wien).2016.158(1).67–76.SCI

22. 葉建忠，劉丕楠，李朋，楊智君，王博，張晶，趙賦*.成人髓母細胞瘤分子亞型的臨床及病理學(xué)特點分析.中華神經(jīng)外科雜志.2016.32 (1).21-24.核心期刊

23. 趙賦，李朋，張晶，杲新晴，楊智君，王博，王興朝，王振民，劉丕楠*.遺傳性2型神經(jīng)纖維瘤病家系基因突變及臨床特點分析.中華神經(jīng)外科雜志.2016.32(1).3-7.核心期刊

24. Wang X, Xu P, Li P, Wang Z, Zhao F, Gao Z, Xu L, Luo YJ, Fan J, Liu Pinan*.Alterations in gray matter volume due to unilateral hearing loss.Scientific Reports.2016.6.25811.SCI

25. Zhao F#, Ohgaki H, Xu L, Giangaspero F, Li C, Li P, Yang Z, Wang B, Wang X, Wang Z, Ai L, Zhang J, Luo L, Liu P*.Molecular subgroups of adult medulloblastoma: a long-term single-institution study.Neuro-Oncology.2016.18 (7).982-990.SCI

26. 張晶, 李春德, 劉丕楠, 李朋, 李仕維, 張順, 趙赤, 趙賦*. 實時熒光定量PCR確定兒童和青少年髓母細胞瘤分子亞型的準(zhǔn)確性分析.中華神經(jīng)外科雜志.2016.32 (9).867–872.核心期刊

27. 李仕維, 劉丕楠, 周強意, 張晶, 張順, 楊智君, 王博, 趙賦*.大鼠坐骨神經(jīng)移植神經(jīng)鞘瘤模型的建立.中華神經(jīng)外科雜志.2016.32(9).1151–1155.核心期刊

28. 趙賦，武麗，王博，楊智君，王振民，王興朝，李朋，張晶，劉丕楠*.聽性腦干反應(yīng)和純音聽閾在聽神經(jīng)瘤早期診斷中的應(yīng)用.中華神經(jīng)外科雜志.2015.31(7).672–675.核心期刊

29. 趙賦，王博，楊智君，王振民，吳勝田，李智，張晶，汪穎，王興朝，劉丕楠*.2型神經(jīng)纖維瘤病前庭神經(jīng)鞘瘤的顯微外科治療.中華神經(jīng)外科雜志.2014.30(11).1153–1156.核心期刊

30. 14. 趙賦，李進軍，張晶，王興朝，王振民，渠沛然，羅麟，劉丕楠*.成人髓母細胞瘤不同病理亞型臨床特征及預(yù)后分析.中華病理學(xué)雜志.2014. 31(2).169–172.核心期刊

31. 趙賦，渠沛然，張晶，王振民，王興朝，楊智君，劉丕楠*.成人髓母細胞瘤的臨床治療及預(yù)后.中華神經(jīng)科雜志.2013.46(7).1–5.核心期刊

32. 趙賦，王博，楊智君，吳勝田，王振民，張晶，劉丕楠*.內(nèi)鏡下經(jīng)鼻入路治療顱底中央?yún)^(qū)惡性腫瘤.中國微侵襲神經(jīng)外科雜志.2013. 18 (5).193–196.核心期刊

33. 趙賦; 張晶;汪穎; 楊智君; 王博; 王興朝; 王振民; 渠沛然; 李朋; 劉丕楠*.2型神經(jīng)纖維瘤病患者臨床各因素與預(yù)后相關(guān)性分析.中華神經(jīng)外科雜志.2013.29(10).980–983.核心期刊

34. 趙賦，張玉琪，王振民，王小平，楊智君，羅麟，F(xiàn)elice Giangaspero，劉丕楠*.促纖維增生／結(jié)節(jié)型髓母細胞瘤病理學(xué)特點及相關(guān)信號通路研究.中華神經(jīng)外科雜志.2012.28(10).1040–1044.核心期刊

主編或副主編的著作/譯著

重要獎項

1. 2型神經(jīng)纖維瘤病臨床診療體系的建立與應(yīng)用推廣 科技進步獎 二等獎 202212

2. 新的人源NF2神經(jīng)鞘瘤移植瘤及細胞系模型建立及應(yīng)用 2022世界神經(jīng)腫瘤大會（WFNOS）最佳摘要獎 202204

3. 神經(jīng)內(nèi)鏡微創(chuàng)治療顱底病變 國家教育部科技進步獎 貳等獎 2011